BS
Bhushan Sudhir Bopardikar
About Bhushan Sudhir Bopardikar
Data last updated:
Bhushan Sudhir Bopardikar is a Nominee Director at Rhea Healthcare Private Limited (since 2021), Director at Tessolve Semiconductor Private Limited (since 2025) and Director at Schott Poonawalla Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Information Technology and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹3,879 Cr; the largest is Rhea Healthcare Private Limited at ₹1,442 Cr (FY 2025). Earlier, Bhushan Sudhir Bopardikar was an Additional Director at Onesource Specialty Pharma Limited (2023) and Additional Director at Steriscience Specialties Private Limited (2024) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 19 May 2021 | 2008 | ₹1,442 Cr (FY 2025) | Active | |
| Director | 13 Nov 2025 | 1993 | ₹1,157 Cr (FY 2025) | Active | |
| Director | 13 May 2025 | 1994 | ₹1,056 Cr (FY 2025) | Active | |
| Nominee Director | 22 Mar 2024 | 2011 | ₹223 Cr (FY 2025) | Active | |
| Partner | 27 Aug 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 14 Aug 2023 | 2007 | ₹1,437 Cr (FY 2026) | Active | |
| Additional Director | 17 May 2024 | 2020 | ₹9.53 Cr (FY 2025) | Active | |
| Nominee Director | 25 Mar 2021 | 2009 | ₹433 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhushan Sudhir Bopardikar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhushan Sudhir Bopardikar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhushan Sudhir Bopardikar
Bhushan Sudhir Bopardikar currently holds 5 directorships: Rhea Healthcare Private Limited (Nominee Director, since 19 May 2021, revenue ₹1,442 Cr (FY 2025)); Tessolve Semiconductor Private Limited (Director, since 13 Nov 2025, revenue ₹1,157 Cr (FY 2025)); Schott Poonawalla Private Limited (Director, since 13 May 2025, revenue ₹1,056 Cr (FY 2025)); Asian Institute Of Nephrology And Urology Private Limited (Nominee Director, since 22 Mar 2024, revenue ₹223 Cr (FY 2025)); Karbonite Ventures Llp (Partner, since 27 Aug 2021).
Bhushan Sudhir Bopardikar was first appointed on 25 Mar 2021 as Nominee Director at Nova Medical Centers Private Limited. The most recent appointment on record is 13 Nov 2025 at Tessolve Semiconductor Private Limited.
The 4 current companies of Bhushan Sudhir Bopardikar that report revenue have a combined latest revenue of ₹3,879 Cr: Rhea Healthcare Private Limited ₹1,442 Cr (FY 2025); Tessolve Semiconductor Private Limited ₹1,157 Cr (FY 2025); Schott Poonawalla Private Limited ₹1,056 Cr (FY 2025); Asian Institute Of Nephrology And Urology Private Limited ₹223 Cr (FY 2025).
Bhushan Sudhir Bopardikar held 3 earlier board appointments: Onesource Specialty Pharma Limited (Additional Director, 14 Aug 2023 to 24 Sep 2023); Steriscience Specialties Private Limited (Additional Director, 17 May 2024 to 19 Sep 2024); Nova Medical Centers Private Limited (Nominee Director, from 25 Mar 2021).
The current boards of Bhushan Sudhir Bopardikar's companies include Ankur Nand Thadani (Rhea Healthcare Private Limited), Cynthia Xin Yu Lau (Rhea Healthcare Private Limited), Lav Agarwal (Rhea Healthcare Private Limited), Mayank Rawat (Rhea Healthcare Private Limited), Murali Sivaraman (Rhea Healthcare Private Limited), Rashmi Satish Joshi (Rhea Healthcare Private Limited), among others.